All Stories

  1. Soluble NKG2D ligands are biomarkers associated with the clinical outcome to immune checkpoint blockade therapy of metastatic melanoma patients

    Article • OncoImmunology, May 2017, Taylor & Francis

    Cristina Maccalli, Francesco Marincola

  2. A collection of annotated and harmonized human breast cancer transcriptome datasets, including immunologic classification

    Article • F1000Research, March 2017, Faculty of 1000, Ltd.

    Dr salha sb Bujassoum Al Bader , Dr Julie Decock, Cristina Maccalli, Jessica Roelands, Ena Wang, Francesco Marincola

  3. Integrating Immune Checkpoint Blockade with Anti-Neo/Mutated Antigens Reactivity to Increase the Clinical Outcome of Immunotherapy

    Article • Vaccines, May 2015, MDPI AG

    Cristina Maccalli

  4. Vaccination in Human Solid Tumors: Recent Progress in the Clinical Arena

    Article • January 2015, Springer Science + Business Media

    Cristina Maccalli

  5. Resistance of Cancer Stem Cells to Cell-Mediated Immune Responses

    Article • January 2015, Springer Science + Business Media

    Cristina Maccalli

  6. Peptide-based vaccines for cancer therapy

    Article • Human Vaccines & Immunotherapeutics, November 2014, Taylor & Francis

    Cristina Maccalli

  7. Autologous Versus Allogeneic Cell-Based Vaccines?

    Article • The Cancer Journal, September 2011, Wolters Kluwer Health

    Cristina Maccalli

  8. TNK cells (NKG2D+ CD8+ or CD4+ T lymphocytes) in the control of human tumors

    Article • Cancer Immunology Immunotherapy, December 2008, Springer Science + Business Media

    Cristina Maccalli

  9. Immunology and immunotherapy of colorectal cancer

    Article • Critical Reviews in Oncology/Hematology, April 2003, Elsevier

    Cristina Maccalli

  10. Multiple sub-sets of Cd4+ and Cd8+ cytotoxic T-cell clones directed to autologous human melanoma identified by cytokine profiles

    Article • International Journal of Cancer, April 1994, Wiley

    Cristina Maccalli